Sanofi-Aventis pins hopes on fat-busting drug
615158
A NEW &quot;miracle&quot; drug for obesity could prove central to the fortunes of manufacturer Sanofi-Aventis, if the French company is successful in bringing it to the market.
409429
A new drug from Sanofi-Aventis reduced significantly episodes of atrial fibrillaton or irregular heart beat in two clinical studies released on Sunday.
712654
Several studies show Sanofi-Aventis' antibiotic Ketek is safe and effective despite reports of liver failure in some patients, U.S. Food and Drug Administration staff said in documents released on Wednesday.
389377
To people who have struggled for a lifetime to lose weight, the new drug called rimonabant sounds like a dream come true. It will make a person uninterested in fattening foods, they have heard from news reports and word of mouth.
501618
Federal health advisers unanimously rejected a weight-loss drug Wednesday after hearing testimony that it increases the risk of suicidal thoughts, even in patients without a history of depression. The manufacturer, Sanofi-Aventis SA, further failed to show the drug rimonabant is safe, the panel said.
128238
Novo Nordisk and Sanofi-Aventis fight over insulin-delivery systems.
494299
Sanofi-Aventis expects to get a decision from U.S. regulators by April 26 on whether it may sell anti-obesity pill and potential blockbuster Acomplia in the world's largest drug market, following a six-month review.
348260
PARIS  - The newly formed pharmaceutical group Sanofi-Aventis published third-quarter sales figures showing a 10.7 percent increase over 12 months in line with expectations.
431957
Not content with having a drug that might merely fight obesity and smoking, the company developing this eagerly anticipated pill will soon launch studies to see if it can treat and prevent clogged arteries and heart disease.
479416
Patients who took a Sanofi-Aventis SA obesity drug in clinical trials were more likely to report suicidal thoughts or actions than others who got a placebo, U.S. drug reviewers said in an analysis released on Monday.
311254
Expectations rose for Sanofi-Aventis's  big new drug hope Acomplia on Friday as the French firm  revealed it would present two-year, rather than one-year, data  on the anti-obesity medicine next week.
579427
Sanofi-Aventis posted higher than expected fourth-quarter profits on Tuesday and predicted more growth for 2007, but a further delay in its key new anti-obesity drug Acomplia hit the shares.
42558
An experimental anti-obesity drug was shown to help people lose weight in the first year, and keep it off in the second, researchers said Tuesday.
223606
French drugmaker Sanofi-Aventis and  Japan&#39;s Taiho Pharmaceutical said combining their S-1 oral  stomach cancer medicine with the drug cisplatin improved  chances of survival compared with S-1 alone.
39535
Sanofi-Aventis said on Friday that U.S. regulators had approved wider use for its colon cancer drug Eloxatin, lifting shares in the world's third-largest pharmaceuticals group.
663544
French drugmaker Sanofi-Aventis has launched a cheap anti-malaria pill that could cut deaths from the killer disease in Africa.
670417
PARIS Sanofi-SynthÃ©labo, which this month completed its $63 billion purchase of a rival drug manufacturer, Aventis, reported Tuesday a 21 percent jump in first-half profit on higher demand for the blood thinner Plavix and the cancer treatment Eloxatin.